- Home
- PHVS vs ACDC Comparison
PHVS vs ACDC Comparison
Compare PHVS & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- ACDC
- Stock Information
- Founded
- PHVS 2015
- ACDC 2014
- Country
- PHVS Switzerland
- ACDC United States
- Employees
- PHVS N/A
- ACDC N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- ACDC Oilfield Services/Equipment
- Sector
- PHVS Health Care
- ACDC Energy
- Exchange
- PHVS Nasdaq
- ACDC Nasdaq
- Market Cap
- PHVS 980.3M
- ACDC 1.1B
- IPO Year
- PHVS 2021
- ACDC 2022
- Fundamental
- Price
- PHVS $18.11
- ACDC $7.88
- Analyst Decision
- PHVS Buy
- ACDC Hold
- Analyst Count
- PHVS 6
- ACDC 5
- Target Price
- PHVS $37.17
- ACDC $7.10
- AVG Volume (30 Days)
- PHVS 29.1K
- ACDC 882.1K
- Earning Date
- PHVS 08-13-2025
- ACDC 08-07-2025
- Dividend Yield
- PHVS N/A
- ACDC N/A
- EPS Growth
- PHVS N/A
- ACDC N/A
- EPS
- PHVS N/A
- ACDC N/A
- Revenue
- PHVS N/A
- ACDC $2,209,700,000.00
- Revenue This Year
- PHVS N/A
- ACDC N/A
- Revenue Next Year
- PHVS N/A
- ACDC $0.09
- P/E Ratio
- PHVS N/A
- ACDC N/A
- Revenue Growth
- PHVS N/A
- ACDC N/A
- 52 Week Low
- PHVS $11.51
- ACDC $3.83
- 52 Week High
- PHVS $25.50
- ACDC $10.70
- Technical
- Relative Strength Index (RSI)
- PHVS 55.94
- ACDC 48.89
- Support Level
- PHVS $17.05
- ACDC $7.15
- Resistance Level
- PHVS $19.00
- ACDC $7.97
- Average True Range (ATR)
- PHVS 1.00
- ACDC 0.66
- MACD
- PHVS 0.05
- ACDC -0.20
- Stochastic Oscillator
- PHVS 70.17
- ACDC 20.56
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.